BPC-157 and Peptides for Injury Recovery: What Does the Research Actually Say?

The claims are appealing – especially when an injury is keeping you from training, competing, or doing the activities you enjoy.

But there is an important distinction between a treatment being promising and a treatment being proven.

So, what does the research actually tell us about peptides like BPC-157 and injury recovery?

What Are Peptides?

Peptides are short chains of amino acids that can act as signaling molecules throughout the body. Many peptides occur naturally, and several peptide-based medications have well-established medical uses.

Think of amino acids like individual LEGO blocks. When many of those blocks are connected, they can form a larger structure – a protein. Peptides are essentially smaller chains of those same building blocks. Because of their smaller size and specific arrangements, different peptides can act like signals that tell cells and tissues to perform certain functions.

The controversy comes from experimental peptides being marketed specifically for musculoskeletal healing, athletic performance, and injury recovery.

BPC-157 – short for Body Protection Compound-157 – has received significant attention for this reason.

Why Is BPC-157 So Popular?

The interest isn’t completely without scientific basis.

Laboratory and animal studies have reported potentially beneficial effects of BPC-157 on several types of musculoskeletal tissue, including muscle, tendon, ligament, and bone. Researchers have proposed several possible mechanisms involving blood-vessel formation, cellular signaling, inflammation, and tissue repair.¹ ²

That sounds promising.

The important catch is that nearly all of this evidence comes from preclinical research rather than high-quality human trials.

A 2025 systematic review examining BPC-157 in orthopedic sports medicine identified 36 relevant studies. Of those, **35 were preclinical studies and only one involved human patients.**¹

That’s a major limitation when determining whether a treatment actually works in people.

Animal Research Isn’t the Same as Human Evidence

Animal studies are an important part of medical research. They can help researchers understand how a substance may work and whether it deserves further investigation.

But results in animals don’t guarantee the same results in humans.

A 2019 review examining BPC-157 and musculoskeletal soft-tissue healing found encouraging findings involving tendon, ligament, and skeletal muscle recovery. However, the research was overwhelmingly based on animal models.²

This means we currently don’t have enough high-quality human evidence to confidently determine:

• How effective BPC-157 is for common sports injuries
• Which injuries may respond best
• The ideal dosage or method of administration
• Potential interactions or side effects
• Long-term safety
• Whether it meaningfully shortens return-to-sport timelines

Those are important unanswered questions.

What About the Human Research?

Human evidence remains extremely limited.

The 2025 systematic review identified only one small retrospective human study related to musculoskeletal pain. Twelve patients with chronic knee pain received an intra-articular BPC-157 injection, with seven reporting pain relief lasting longer than six months.¹

While interesting, a study this small and without the controls of a randomized clinical trial cannot establish that BPC-157 is an effective treatment.

The same review found no clinical safety data in humans among the included studies.¹

That doesn’t prove BPC-157 is unsafe. It means we currently don’t have enough evidence to confidently establish its safety profile in humans.

Why Personal Success Stories Aren’t Enough

You may know an athlete who used BPC-157 and says their injury healed dramatically faster.

Their experience may be completely genuine.

The problem is determining why they improved.

Most injured athletes are doing several things simultaneously. They may reduce their training volume, begin physical therapy, improve sleep and nutrition, gradually reload the injured tissue, and simply give the injury more time to heal.

Without controlled research, it’s difficult to determine how much of the improvement came from the peptide itself.

That’s why testimonials can generate interesting questions, but they can’t replace clinical trials.

What Does Have Stronger Evidence for Injury Recovery?

For most musculoskeletal injuries, we have considerably stronger evidence supporting progressive rehabilitation and appropriate loading.

Depending on the injury, that may include:

• Progressive strength training
• Tendon or muscle loading
• Restoring mobility when necessary
• Gradual return to running and jumping
• Sport-specific exercise
• Managing training volume and intensity
• Adequate nutrition and sleep

These interventions may not sound as exciting as a compound promising accelerated healing, but they address something every athlete eventually needs:

Restoring the injured tissue’s ability to tolerate the demands of training and sport.

Even if future research establishes a role for peptides in tissue healing, rehabilitation would still be necessary to restore strength, movement, power, coordination, and confidence.

The Bottom Line on BPC-157

BPC-157 is an interesting and evolving area of research.

Preclinical studies provide legitimate reasons for scientists to continue investigating it. However, the current evidence for musculoskeletal recovery is dominated by laboratory and animal research, while high-quality human evidence and clinical safety data remain very limited.¹ ²

For now, claims that BPC-157 has been proven to dramatically accelerate human tendon, ligament, muscle, or bone healing go beyond what the research can currently support.

Patients considering BPC-157 or other experimental peptides should discuss the potential risks, benefits, and regulatory considerations with an appropriately qualified medical provider.

At Zeek PT & Recovery in North Austin, our focus is on what rehabilitation can control: restoring movement, progressively rebuilding strength and tissue capacity, and preparing your body for the demands of training, competition, and everyday life.

Because healing the injury is only part of the process.

Recover. Rebuild. Perform.

References

1. Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS Journal. 2025;21(4):485-495. doi:10.1177/15563316251355551.
   This systematic review identified 36 studies examining BPC-157, 35 of which were preclinical and only one clinical. It found promising musculoskeletal findings in preclinical models but no clinical human safety data.
2. Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell and Tissue Research. 2019;377:153-159. doi:10.1007/s00441-019-03016-8.
   This review examined experimental evidence surrounding BPC-157 and tendon, ligament, and skeletal muscle healing, highlighting promising preclinical findings while demonstrating the limited translation to human clinical research.

Because high-quality human research on BPC-157 remains extremely limited, fewer references are included here than in our other evidence-based articles. Rather than adding lower-quality studies simply to increase the reference count, we’ve prioritized the most relevant peer-reviewed reviews of the available evidence.

Meta Description: Does BPC-157 actually help injuries heal faster? Learn what current research says about peptides, tendon and muscle recovery, human evidence, and the limitations of BPC-157.